NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 50 filers reported holding NEURODERM LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,748,000 | -45.1% | 147,756 | -57.8% | 0.74% | -35.4% |
| Q2 2017 | $10,468,000 | -19.4% | 350,085 | -28.4% | 1.14% | -24.5% |
| Q1 2017 | $12,990,000 | +32.7% | 489,267 | +11.0% | 1.52% | +39.9% |
| Q4 2016 | $9,786,000 | +226.7% | 440,799 | +172.1% | 1.08% | +268.7% |
| Q3 2016 | $2,995,000 | +75.6% | 161,971 | +54.3% | 0.29% | +67.0% |
| Q2 2016 | $1,706,000 | – | 104,971 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERTEX ONE ASSET MANAGEMENT INC. | 29,200 | $1,134,000 | 0.19% |
| Opera Trading Capital | 3,611 | $141,000 | 0.03% |
| IFP Advisors, Inc | 600 | $23,000 | 0.00% |
| Ancora Advisors LLC | 10,000 | $0 | 0.00% |
| Focused Wealth Management, Inc | 32 | $1,000 | 0.00% |